NATCO Pharma Limited (NSE:NATCOPHARM)
India
· Delayed Price · Currency is INR 904.90
+11.30 (1.26%)
Jun 25, 2026, 3:29 PM IST
NATCO Pharma Employees
NATCO Pharma had 4,199 employees as of March 31, 2025. The number of employees increased by 183 or 4.56% compared to the previous year.
Employees
4,199
Change (1Y)
183
Growth (1Y)
4.56%
Revenue / Employee
9.71M INR
Profits / Employee
3.38M INR
Market Cap
161.86B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 16,571 |
| Cohance Lifesciences | 1,212 |
| Alivus Life Sciences | 2,203 |
| Eris Lifesciences | 3,354 |
| Piramal Pharma | 5,476 |
| Strides Pharma Science | 3,301 |
| Akums Drugs and Pharmaceuticals | 7,536 |
| Sudeep Pharma | 740 |
NATCO Pharma News
- 5 days ago - Pharma sector stocks rally today, June 23: IPCA Labs up 2.54%, Dr. Reddys Lab gains 2.47%, Natco Pharma rises 2.45% - Business Upturn
- 10 days ago - Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01% - Business Upturn
- 16 days ago - Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36% - Business Upturn
- 23 days ago - Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79% - Business Upturn
- 24 days ago - Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63% - Business Upturn
- 25 days ago - Lupin And Natco Receive FDA Approval For Eribulin Mesylate Injection - Nasdaq
- 25 days ago - Lupin, Natco Receive FDA Approval For Eribulin Mesylate Injection - Nasdaq
- 25 days ago - Natco Pharma and Lupin secure U.S. FDA approval for Eribulin Mesylate Injection - Business Upturn